Mohammed Altigani Abdalla
Overview
Explore the profile of Mohammed Altigani Abdalla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jamialahmadi T, Azizmohammad Looha M, Jangjoo S, Emami N, Abdalla M, Ganjali M, et al.
J Diabetes Metab Disord
. 2025 Jan;
24(1):54.
PMID: 39834350
Objectives: Liver fibrosis resulting from nonalcoholic fatty liver disease (NAFLD) and metabolic disorders is highly prevalent in patients with severe obesity and poses a significant health challenge. However, there is...
2.
Alam Z, Alseari S, Alameemi M, Alzaabi M, Alkhoori R, Ostlundh L, et al.
Heliyon
. 2025 Jan;
10(24):e40603.
PMID: 39759288
Background: Polycystic ovary syndrome (PCOS) is a significant contributor to female infertility and other various metabolic disorders. This systematic review estimates the prevalence of PCOS among infertile women in the...
3.
Roomy M, Hussain K, Behbehani H, Abu-Farha J, Al-Harris R, Ambi A, et al.
Front Endocrinol (Lausanne)
. 2024 May;
15:1364503.
PMID: 38715796
Obesity has become a global epidemic in the modern world, significantly impacting the global healthcare economy. Lifestyle interventions remain the primary approach to managing obesity, with medical therapy considered a...
4.
Alam Z, Abdalla M, Alseiari S, Alameemi M, Alzaabi M, Alkhoori R, et al.
Womens Health (Lond)
. 2023 Mar;
19:17455057231160940.
PMID: 36999302
Background: Polycystic ovarian syndrome, a common endocrine disorder, is an important cause of infertility among women of reproductive age. Within the Gulf Cooperation Council countries, polycystic ovarian syndrome is found...
5.
Abdalla M, Shah N, Deshmukh H, Sahebkar A, Ostlundh L, Al-Rifai R, et al.
Ther Adv Endocrinol Metab
. 2022 Oct;
13:20420188221127142.
PMID: 36225721
Context: Polycystic ovary syndrome (PCOS) is one of the commonest endocrine disorders affecting women of reproductive age, and metformin is a widely used medication in managing this condition. Aim: To...
6.
Abdalla M, Shah N, Deshmukh H, Sahebkar A, Ostlundh L, Al-Rifai R, et al.
Arch Gynecol Obstet
. 2022 Apr;
307(5):1347-1376.
PMID: 35434762
Context: Polycystic ovary syndrome (PCOS) is a complex endocrine disease that affects women of reproductive age and is characterised by biochemical and clinical androgen excess. Aim: To evaluate the efficacy...
7.
Deshmukh H, Shah N, Papageorgiou M, Abdalla M, Lhaf F, Aye M, et al.
Bone
. 2021 Dec;
155:116285.
PMID: 34902614
Introduction: There is conflicting data on the effect of polycystic ovary syndrome (PCOS) on bone mineral density (BMD) and fracture risk. Recent genetic data suggest that men may also carry...
8.
Shah N, Abdalla M, Deshmukh H, Sathyapalan T
Ther Adv Endocrinol Metab
. 2021 Sep;
12:20420188211042145.
PMID: 34589201
Diabetes mellitus (DM) is a chronic, progressive, and multifaceted illness resulting in significant physical and psychological detriment to patients. As of 2019, 463 million people are estimated to be living...
9.
Yaribeygi H, Farrokhi F, Abdalla M, Sathyapalan T, Banach M, Jamialahmadi T, et al.
J Diabetes Res
. 2021 Jul;
2021:6518221.
PMID: 34258291
Glucagon-like peptide-1 receptor (GLP-1R) agonists are a class of newly introduced antidiabetic medications that potentially lower blood glucose by several molecular pathways. DPP-4 inhibitors are the other type of novel...
10.
Abdalla M, Deshmukh H, Mohammed I, Atkin S, Reid M, Sathyapalan T
Front Physiol
. 2021 Jun;
12:652559.
PMID: 34108885
Free androgen index (FAI) and anti-Mullerian hormone (AMH) are independently associated with polycystic ovary syndrome (PCOS). This study aimed to describe the relationship between these two markers and health-related quality...